FDA seeking input on regulatory status of "maintaining healthy cholesterol" claims.
This article was originally published in The Tan Sheet
Executive Summary
FDA SEEKING INPUT ON "MAINTAINING HEALTHY CHOLESTEROL" CLAIMS to help determine when such statements cross the line to disease claims. The agency notes in its April 29 proposed rule on dietary supplement structure/function claims that it "welcomes comment" on the basis for the distinction between maintaining normal function and preventing or treating abnormal function and "on factors that help distinguish between claims relating to normal, healthy function that do not imply disease treatment or prevention and those that do."